ROSEN, Leading Investor Counsel, Encourages Homology Medicines, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FIXXNewsfile Corp • 05/02/22
ROSEN, Top Ranked Investor Counsel, Encourages Homology Medicines, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FIXXNewsfile Corp • 04/29/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Homology Medicines (FIXX) Investors with Significant Losses to Contact Firm's Attorneys Before May Deadline in Securities Class ActionNewsfile Corp • 04/29/22
ROSEN, A LEADING LAW FIRM, Encourages Homology Medicines, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FIXXPRNewsWire • 04/28/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Homology Medicines (FIXX) Investors with Significant Losses to Contact Firm's Attorneys, Securities Fraud Class Action FiledNewsfile Corp • 04/27/22
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FIXXNewsfile Corp • 04/25/22
FIXX ALERT: Hagens Berman, National Trial Attorneys, Encourages Homology Medicines (FIXX) Investors with Significant Losses to Contact Firm's Attorneys, Securities Fraud Class Action FiledNewsfile Corp • 04/21/22
ROSEN, National Trial Lawyers, Encourages Homology Medicines, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FIXXNewsfile Corp • 04/21/22
Homology Medicines Announces Promotion of Albert Seymour, Ph.D., to PresidentGlobeNewsWire • 04/21/22
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FIXXPRNewsWire • 04/20/22
ROSEN, A Leading Law Firm, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FIXXNewsfile Corp • 04/19/22
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Homology Medicines, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - FIXXNewsfile Corp • 04/16/22
FIXX INVESTOR NOTICE: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - FIXXNewsfile Corp • 04/15/22
FIXX INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Homology Medicines (FIXX) Investors with Significant Losses to Contact Firm, Securities Fraud Class Action FiledNewsfile Corp • 04/14/22
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors With Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - FIXXNewsfile Corp • 04/12/22
FIXX Stock News: Robbins LLP Investigates Homology Medicines, Inc. (FIXX) for ShareholdersBusiness Wire • 04/12/22
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FIXXNewsfile Corp • 04/10/22
NATIONALLY RANKED ROSEN LAW FIRM Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FIXXPRNewsWire • 04/09/22
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FIXXNewsfile Corp • 04/07/22
Bronstein, Gewirtz & Grossman, LLC Reminds Homology Medicines, Inc. (FIXX) Shareholders of Class Action and Encourages Investors to Contact the FirmNewsfile Corp • 04/07/22
FIXX CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Investors in Homology Medicines (FIXX) with Significant Losses to Contact Firm, Securities Fraud Class Action FiledNewsfile Corp • 04/06/22
HOMOLOGY MEDICINES, INC. (NASDAQ: FIXX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Homology Medicines, Inc. (NASDAQ: FIXX)PRNewsWire • 04/05/22
ROSEN, A TOP RANKED FIRM, Encourages Homology Medicines, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FIXXNewsfile Corp • 04/03/22
FIXX DEADLINE: Investors with Substantial Losses Have Opportunity to Lead Homology Medicines, Inc. Class Action LawsuitPRNewsWire • 04/02/22
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – FIXXBusiness Wire • 04/02/22
